A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Ustekinumab Therapy in Subjects With Moderately to Severely Active Crohn's Disease Previously Treated With TNF Antagonist Therapy
收藏DataCite Commons2025-12-20 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00004769/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
A medical research study in adult patients who have moderate to severe Crohn's disease designed to determine whether or not treatment with an experimental drug called ustekinumab (or CNTO1275) is safe or not and to determine if the treatment will reduce the symptoms of Crohn's disease.
提供机构：
Vivli
创建时间：
2019-09-19
